Nureca hits the roof after Hornbill Orchid India acquires 1.95% stake

Capital Market 

Nureca hit an upper circuit of 5% at Rs 1,627.50 after Hornbill Orchid India acquired 1.95 lakh equity shares of the company via bulk deal on Wednesday, 23 June 2021.

Hornbill Orchid India Fund bought 1,95,766 equity shares (or 1.95% stake) of the company at Rs 1,549.97 per equity share via bulk deals on the BSE yesterday, 23 June 2021.

On a consolidated basis, Nureca's net profit surged 63.4% to Rs 3.89 crore on 3.4% fall in net sales to Rs 31.84 crore in Q4 March 2021 over Q4 March 2020.

Nureca is a B2C company engaged in the business of home healthcare and wellness products. The company has a diversified product portfolio, which primarily caters to home healthcare sector. The company has most of the product lines supporting home health market in India, making it a one-stop solution provider. The company enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle.

Shares of Nureca entered the stock exchanges on 25 February 2021. The stock was listed at Rs 634.95, a premium of 58.7% to the initial public offer (IPO) price of Rs 400 a share. The IPO was open between 15 February and 17 February 2021. It was subscribed 39.93 times. The price band for the IPO was set at Rs 396-400 per share.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, June 24 2021. 10:55 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU